recent
outbreak
sever
acut
respiratori
syndrom
sar
initi
flurri
research
activ
improv
earli
detect
prevent
treatment
sar
caus
agent
identifi
coronaviru
cov
belong
previous
identifi
group
probabl
origin
wild
anim
reservoir
recent
studi
bosch
et
describ
strategi
interf
diseas
progress
earli
stage
block
fusion
sarscov
host
cell
process
mediat
fusion
peptid
viru
envelop
spike
protein
author
explor
potenti
therapeut
valu
peptid
deriv
region
sarscov
spike
protein
similar
class
fusion
protein
virus
ntermin
half
protein
contain
receptorbind
domain
ctermin
portion
region
contain
two
heptad
repeat
region
studi
virus
known
peptid
deriv
domain
inhibit
infect
like
interf
conform
chang
essenti
direct
membran
fusion
therefor
essenti
initi
infect
accordingli
author
test
potenti
exogen
peptid
deriv
sarscov
inhibitor
sar
infect
vero
cell
cultur
found
peptid
inhibitori
concentrationdepend
manner
investig
believ
inhibitori
effect
sarscov
peptid
provid
basi
develop
therapeut
drug
sar
articl
dovetail
articl
juang
et
issu
laboratori
investig
explor
possibl
sensit
accur
earli
diagnosi
sarscov
detect
multipl
virusspecif
genom
sequenc
sarscov
studi
illustr
mani
effort
underway
achiev
better
understand
pathogenesi
earli
detect
treatment
sar
arief
suriawinata
md
bosch
bj
martina
van
der
zee
r
et
al
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
inhibit
use
spike
protein
heptad
repeatderiv
peptid
proc
natl
acad
sci
usa
juang
jl
chen
tc
jiang
ss
et
al
coupl
multiplex
rtpcr
gene
chip
assay
sensit
semiquantit
detect
sever
acut
respiratori
syndromecoronaviru
lab
invest
multipl
myeloma
character
accumul
neoplast
plasma
cell
bone
marrow
multipl
osteolyt
defect
skeleton
postul
malign
plasma
cell
secret
factor
respons
recruit
activ
osteoclast
lead
bone
destruct
multipl
inflammatori
cytokin
tumor
necrosi
receptor
activ
nuclear
factor
ligand
rankl
known
involv
regul
osteoclastogenesi
macrophag
inflammatori
protein
mip
anoth
chemokin
chemotact
activ
matur
osteoclast
osteoclast
precursor
also
play
signific
role
osteoclastogenesi
believ
involv
causat
lytic
lesion
multipl
myeloma
recent
paper
hashimoto
et
correl
abil
myeloma
cell
secret
extent
lytic
bone
lesion
level
biochem
bone
marker
patient
multipl
myeloma
urinari
level
deoxypyridinolin
dpd
use
marker
bone
absorpt
serum
bonespecif
alkalin
phosphatas
balp
osteocalcin
marker
final
miner
process
bone
format
use
marker
bone
format
studi
found
direct
correl
level
urinari
dpd
suggest
causeandeffect
relationship
contrast
found
correl
mip
level
serum
osteocalcin
serum
balp
osteocalcin
level
also
significantli
elev
patient
advanc
diseas
conclud
play
causal
role
develop
multipl
myeloma
bone
lesion
suggest
multipl
myeloma
cell
caus
imbal
bone
turnov
lead
rapid
destruct
bone
issu
toh
et
report
express
macrophag
distal
tibia
rat
adjuv
arthriti
exhibit
mark
bone
destruct
studi
demonstr
import
role
recruit
osteoclast
precursor
stimulatori
osteoclastogenesi
cytokin
express
may
signific
caus
bone
destruct
multipl
myeloma
adjuv
arthriti
sunil
badv
md
hashimoto
abe
oshima
et
al
abil
myeloma
cell
secret
macrophag
inflammatori
protein
mip
correl
lytic
bone
lesion
patient
multipl
myeloma
br
j
hematol
toh
k
kukita
wu
z
et
al
possibl
involv
recruit
osteoclast
progenitor
distal
tibia
rat
adjuv
arthriti
lab
invest
